Aytu BioScience (AYTU) Stock: Next Big Thing… MiOXSYS® cnafinance.com/aytu-bioscienc… via @@CNAFinance

October Natesto results are in! Check them out here:aytubio.com/category/lates… prn.to/2ndCWmu

Aytu BioScience (AYTU) Stock: Posts Record Monthly Sales For Its TRT Product, Natesto® cnafinance.com/aytu-bioscienc…

Aytu BioScience, Inc. to Present at the 10th Annual LD Micro Main Event 14news.com/story/36951785…

The specialty pharmaceutical race has just begun, but in the field of urology, there is only one leader. buff.ly/2AeYDr5 #BTS18 $AYTU #smallcap Demy Colton Aytu BioScience EBD Group

Aytu BioScience Pushes Natesto® Sales To New Record High cnafinance.com/aytu-bioscienc… via @@CNAFinance

Aytu BioScience (AYTU) Stock’s Perfect Trifecta: Natesto®, MiOXSYS®, And Now Fiera® cnafinance.com/aytu-bioscienc… via @@CNAFinance

Aytu BioScience Announces Appointment of David Green as Chief Financial Officer healthtechnologynet.com/articles/viewa…

We have a CFO! Read about him here! prn.to/2zjz7jD

Stop by and see us at the Biotech Showcase in San Francisco! prn.to/2BTrxL7

Aytu Women's Health Release: New Study Proves Efficacy of Fiera, a Personal Care Device, in Female Sexual Arousal and Desire | BioSpace biospace.com/article/releas… #jobs

Aytu BioScience (AYTU) Stock: Why 2018 May Be The  Breakthrough Year cnafinance.com/aytu-bioscienc… via @@CNAFinance

Aytu BioScience Gets A Double Bonus From TLANDO® and Jatenzo® Misses cnafinance.com/aytu-bioscienc… via @@CNAFinance

- Harvard Health health.harvard.edu/mens-health/re…

Aytu Bioscience (AYTU) Stock: Gets A Boost On Delays For Antares Pharma’s, Xyosted™ via @CNAFinance cnafinance.com/aytu-bioscienc…

Our fiscal second quarter 2018 results and business update call is next week! prn.to/2DPWalS

Join us for our Q2 earnings call today! prn.to/2Epijer

Natesto is rockin' it each and every month! prn.to/2EUCKjj

We received market registration for the MiOXSYS® System in Mexico! prn.to/2tnG1Dm

Aytu BioScience Announces Exercise of Underwriters' Over-Allotment Option accesswire.com/viewarticle.as…